Biotech · Private company
Remix Therapeutics
Track this companyFree. Adds Remix Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- REM-422Phase 2 · Adenoid Cystic CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- REM-422Phase 1 · Myelodysplastic SyndromesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study of REM-422 in Patients With AML or Higher Risk MDSPHASE1 · RECRUITING · started Apr 26, 2024ClinicalTrials.gov NCT06297941 · fetched Nov 12, 2026
- Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic CarcinomaPHASE1_PHASE2 · RECRUITING · started Dec 20, 2023ClinicalTrials.gov NCT06118086 · fetched Nov 12, 2026